NDUFS8 and Cognitive impairment: These results indicated that NDUFS8 might serve as a promising biomarker for early diagnosis in CCH-induced cognitive impairment and redefines therapeutic strategies by simultaneously targeting transcriptional regulation and protein stabilization pathways.